WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H558497
CAS#: 112143-77-8
Description: Khardin is a bioactive chemical.
Hodoodo Cat#: H558497
Name: Khardin
CAS#: 112143-77-8
Chemical Formula: C12H12ClN5O4S
Exact Mass: 357.03
Molecular Weight: 357.700
Elemental Analysis: C, 40.29; H, 3.38; Cl, 9.91; N, 19.58; O, 17.89; S, 8.96
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Khardin;
IUPAC/Chemical Name: 2-chloro-N-((4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoyl)benzenesulfonamide
InChi Key: VJYIFXVZLXQVHO-UHFFFAOYSA-N
InChi Code: InChI=1S/C12H12ClN5O4S/c1-7-14-10(17-12(15-7)22-2)16-11(19)18-23(20,21)9-6-4-3-5-8(9)13/h3-6H,1-2H3,(H2,14,15,16,17,18,19)
SMILES Code: VJYIFXVZLXQVHO-UHFFFAOYSA-N
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 357.70 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1: Gordon KB, Colombel JF, Hardin DS. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis. N Engl J Med. 2016 Nov 24;375(21):2102. doi: 10.1056/NEJMc1610828. PubMed PMID: 27959738.
2: Hardin C. Carl Hardin, attorney for the TDA, reports on recent legislative session. J Houston Dist Dent Soc. 1967 Aug;39(8):7-8. PubMed PMID: 5233282.
3: Hardin RE, DeCosky A. A Journal interview with Dr. Rexford E. Hardin. Ohio Dent J. 1977 Nov;51(11):22-6. PubMed PMID: 273826.
4: Hardin J. Regulating cell-cell junctions from A to Z. J Cell Biol. 2016 Apr 25;213(2):151-3. doi: 10.1083/jcb.201604016. PubMed PMID: 27114498; PubMed Central PMCID: PMC4862870.
5: Hardin SE. Leadership Assessment in Collegiate Recreation and Athletics. New Dir Stud Leadersh. 2015 Fall;2015(147):99-108. doi: 10.1002/yd.20147. Review. PubMed PMID: 26895018.
6: Hardin SR. Vulnerability of older patients in critical care. Crit Care Nurse. 2015 Jun;35(3):55-61. doi: 10.4037/ccn2015995. PubMed PMID: 26033101.
7: Hardin J. "Healing is a Done Deal": Temporality and Metabolic Healing Among Evangelical Christians in Samoa. Med Anthropol. 2016 Mar-Apr;35(2):105-18. doi: 10.1080/01459740.2015.1092143. Epub 2015 Oct 5. PubMed PMID: 26436693.
8: Cattet J, Hardin DS. On the Nose. Before purchasing a diabetes alert dog, read these pointers. Diabetes Forecast. 2014 Nov;67(11):28, 30. PubMed PMID: 25571753.
9: Hardin SR. Caring for older adults in critical care. Crit Care Nurs Clin North Am. 2014 Mar;26(1):xi-xiii. doi: 10.1016/j.ccell.2013.10.010. Epub 2013 Nov 11. PubMed PMID: 24484932.
10: Hardin C. A 'fitting' message: exercise more, eat less. Mo Med. 2014 Jan-Feb;111(1):39-40. PubMed PMID: 24645296.
11: Hardin SR. Ethnogeriatrics in critical care. Crit Care Nurs Clin North Am. 2014 Mar;26(1):21-30. doi: 10.1016/j.ccell.2013.10.009. Review. PubMed PMID: 24484921.
12: Burans C, Smulian JC, Rochon ML, Lutte J, Hardin W. 3-dimensional ultrasound assisted counseling for conjoined twins. J Genet Couns. 2014 Feb;23(1):29-32. PubMed PMID: 23797965.
13: Bloedel K, Skhal K. Not just for celebrities: collaborating with a PR representative to market library education services. Med Ref Serv Q. 2006 Fall;25(3):33-43. PubMed PMID: 16893845.
14: Hardin N. Setting the stage for delivery of safer imaging. Radiol Manage. 2013 Nov-Dec;35(6):9-11. PubMed PMID: 24475522.
15: Hardin R, Jacobs LK. Lymphedema: still a problem without an answer. Oncology (Williston Park). 2012 Mar;26(3):256-7. PubMed PMID: 22545307.
16: Barnes M, Linthicum C, Hardin C. Cold, red, itching, and miserable. Mil Med. 2013 Sep;178(9):e1043-4. doi: 10.7205/MILMED-D-13-00120. PubMed PMID: 24005556.
17: Yang Z, Sun X, Hardin JW. A non-iterative implementation of Tango's score confidence interval for a paired difference of proportions. Stat Med. 2013 Apr 15;32(8):1336-42. doi: 10.1002/sim.5561. Epub 2012 Aug 15. PubMed PMID: 22893498.
18: Hardin KJ, Hardin DM. Medical Spanish programs in the United States: a critical review of published studies and a proposal of best practices. Teach Learn Med. 2013;25(4):306-11. doi: 10.1080/10401334.2013.827974. Review. PubMed PMID: 24112199.
19: Hardin D. Echoes of a profession in crisis. MLO Med Lab Obs. 2009 Apr;41(4):6. PubMed PMID: 19459241.
20: Hardin J. An MBoC favorite: Cytokinesis and midzone microtubule organization in Caenorhabditis elegans require the kinesin-like protein ZEN-4. Mol Biol Cell. 2012 Aug;23(16):3025. doi: 10.1091/mbc.E12-02-0149. PubMed PMID: 22891030; PubMed Central PMCID: PMC3418298.
